TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05636930

Intervention type: OTHER
Intervention: Test the accuracy of the wearable device
Description: No intervention was done for the subjects
Study: NCT06185959

Intervention type: BEHAVIORAL
Intervention: Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
Description: Participants will be individuals enrolling in a 1.5 hour weekly therapy group lasting 12 weeks and will be invited to participate in research on group processes and outcomes. The psychoeducation and process group will be a 12-session weekly closed group with 10-15 participants per group (2-3 groups total) conducted via Zoom to enhance accessibility and reduce barriers to care. Groups will be co-led by licensed clinical psychologists with experience providing both group psychotherapy and culturally responsive services. Group sessions will include brief check-ins, collaborative agenda-setting, a mini-didactic, individual reflection, and group discussion. The didactics curriculum will include topics such as intergenerational trauma, cultural differences in emotional expression, the model minority myth, family dynamics, racism, and positive connections to culture.
Study: NCT05953896

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel
Description: For the Hyaluronic acid gel group: HA gel was injected 2-3mm apical to the coronal tip of the involved papillae and the needle was directed coronally with an angulation of 45° to the long axis of the tooth, and the bevel directed apically until papilla became blanched. The injection was given at each papilla at the following intervals baseline, one week and two weeks.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Multilayer L-PRF membranes
Description: For the multilayer L-PRF group: A single semilunar incision is made in the buccal vestibule, apical to the muco-gingival junction in the mid interproximal area of the papilla to be treated.Tunneling of the incisions has maintained the full height and thickness of the gingiva. Multilayer L-PRF membranes were prepared according to Pinto's protocol immediately prior to the surgery and placed in the tunnel then incision was closed with simple interrupted sutures.
Study: NCT04824118

Intervention type: DIAGNOSTIC_TEST
Intervention: Thromboelastometry
Description: Point of Care Test for clotting parameters (ClotPro device)

Intervention type: DIAGNOSTIC_TEST
Intervention: Thromboelastometry
Description: Point of Care Test for clotting parameters (ClotPro device)

Intervention type: DIAGNOSTIC_TEST
Intervention: Thromboelastometry
Description: Point of Care Test for clotting parameters (ClotPro device)

Intervention type: DIAGNOSTIC_TEST
Intervention: Thromboelastometry
Description: Point of Care Test for clotting parameters (ClotPro device)

Intervention type: DIAGNOSTIC_TEST
Intervention: Clotting Studies
Description: Standard laboratory tests for clotting:~* International normalised ratio (INR)~* Prothrombin time (PT)~* adjusted partial thromboplastin time (aPTT)~* fibrinogen

Intervention type: DIAGNOSTIC_TEST
Intervention: Clotting Studies
Description: Standard laboratory tests for clotting:~* International normalised ratio (INR)~* Prothrombin time (PT)~* adjusted partial thromboplastin time (aPTT)~* fibrinogen

Intervention type: DIAGNOSTIC_TEST
Intervention: Clotting Studies
Description: Standard laboratory tests for clotting:~* International normalised ratio (INR)~* Prothrombin time (PT)~* adjusted partial thromboplastin time (aPTT)~* fibrinogen

Intervention type: DIAGNOSTIC_TEST
Intervention: Clotting Studies
Description: Standard laboratory tests for clotting:~* International normalised ratio (INR)~* Prothrombin time (PT)~* adjusted partial thromboplastin time (aPTT)~* fibrinogen

Intervention type: DIAGNOSTIC_TEST
Intervention: Full Blood Count
Description: For platelet count

Intervention type: DIAGNOSTIC_TEST
Intervention: Full Blood Count
Description: For platelet count

Intervention type: DIAGNOSTIC_TEST
Intervention: Full Blood Count
Description: For platelet count

Intervention type: DIAGNOSTIC_TEST
Intervention: Full Blood Count
Description: For platelet count

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantitative hCG
Description: Serum human chorionic gonadotrophin

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantitative hCG
Description: Serum human chorionic gonadotrophin

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantitative hCG
Description: Serum human chorionic gonadotrophin

Intervention type: DIAGNOSTIC_TEST
Intervention: Pregnancy Test
Description: Point of care urinary pregnancy test
Study: NCT04759391

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Pelvic floor muscle training program planned under the supervision of a physiotherapist was applied and followed to the exercise group, using the digital application.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle recommendations
Description: Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lifestyle recommendations
Description: Information was given within the scope of lifestyle recommendations (fluid intake, diet, constipation, weight control, smoking related to lower urinary system symptoms
Study: NCT04536181

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Description: 12 weeks prednisolone treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 12 weeks simulated tablets
Study: NCT04703712

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lens extraction combined with goniosynechialysis
Description: The patients enrolled underwent phacoemulsification combined with goniosynechialysis surgery.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trabeculectomy surgery
Description: The patients enrolled underwent trabeculectomy surgery
Study: NCT05167955

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based cognitive intervention based on the behavioural change techniques taxonomy
Description: An online mindfulness-based cognitive intervention is used as a proposed treatment intervention for erectile dysfunction among African- Caribbean men based in the United Kingdom.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness based cognitive intervention based on the behavioural change techniques taxonomy
Description: An online mindfulness-based cognitive intervention is used as a proposed treatment intervention for erectile dysfunction among African- Caribbean men based in the United Kingdom.
Study: NCT06354387

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alectinib (Alecensa), Nivolumab (Opdivo)
Description: Alectinib (Alecensa) in Combination with Nivolumab (Opdivo)
Study: NCT04622813

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nefopam, ketoprofen, paracetamol
Description: Patients in this group will receive Nefopam and Ketoprofen in addition to the paracetamol intraoperatively prior to the anticipated end of the surgery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline infusion, ketoprofen, paracetamol
Description: Patients in this group will receive one placebo infusion (saline infusion) in addition to the ketoprofen and paracetamol intraoperatively prior to the anticipated end of the surgery
Study: NCT06504199

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Description: No dose adjustment of Obinutuzumab is allowed.
Study: NCT05575375

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Values Affirmation + Usual Care
Description: Participants will engage in a brief values-affirmation exercise to target personal motivation and openness to medication adherence. The interventionist will then review tailored medication education and individual skills training recommendations. The participant's study medication monitoring devices will be labeled with the participants' most important core value(s). Participants will also continue with their usual care.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Participants will be asked to continue with their usual care (e.g., cardiac rehabilitation, ongoing medical management)
Study: NCT05487846

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Navigation
Description: Receive peer navigation services

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Genetic Counseling
Description: Receive genetic counseling

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Genetic Counseling
Description: Receive genetic counseling

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study: NCT03171129

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adaptive Dynamic Inspiratory Nasal Apparatus
Description: Oxygen will be administered via ADINA

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High flow Nasal Canula
Description: Oxygen will be administered via nasal canula
Study: NCT05448651

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UPB-101
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UPB-101
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UPB-101
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: UPB-101
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneous injection
Study: NCT05963581

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Salsa Dancing
Description: Participants will complete salsa dancing classes in central Oxford with instructor(s) from the Oxford University Salsa Society
Study: NCT05692427

Intervention type: DEVICE
Group type: OTHER
Intervention: Cryopen - Cryotherapy
Description: Cryotherapy with N20
Study: NCT06336109

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypertonic saline knee and shoulder injection
Description: 0.25 mL injection with hypertonic saline (7%) in the infrapatellar fat pad.~1.2 mL injection with hypertonic saline (7%) in the deltoid muscle.
Study: NCT05321264

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational nursing intervention
Description: Four weekly individualized intervention sessions, with a duration of 40 minutes.
Study: NCT04710628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200 mg will be administered to patients as 30-minute intravenous infusion (a window of -5 minutes and +10 minutes is permitted) every 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib 10 mg
Description: Lenvatinib 20 mg (2 capsules of 10 mg) will be administered daily at the same time, with or without food. At the day 1 of each cycle, lenvatinib will be administered within 4 hours after finishing pembrolizumab (lenvatinib after pembrolizumab)
Study: NCT04695444

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: nasotracheal tube (Ring-Adair-Elwin)
Description: different materials for nasotracheal intubation conventional PVC tube

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nasotracheal tube (Ring-Adair-Elwin)
Description: different materials for nasotracheal intubation conventional PVC tube with rubber suction catheter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nasotracheal tube (portex)
Description: different materials for nasotracheal intubation velvet soft PVC tube.
Study: NCT04193982

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar
Description: Patient receives Saraglitazar 4mg once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin E
Description: Patient receive Vitamin E 400mg twice daily after food for 6 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination drug
Description: Patient receives Vitamine E 400mg twice daily and Saraglitazar 4 mg once daily for 6 months

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle Changes
Description: Patients receives dietary advise and does exercise in form of aerobic and targets 7 to 10 percent weight loss in 6 months
Study: NCT06504199

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Description: Zanubrutinib was allowed to be titrated to 80 mg bid or 80 mg qd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide was allowed to be titrated to 15 mg/day (induction phase) or 5 mg/day (maintenance phase).
Study: NCT06022198

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar Lavage
Description: Bronchoalveolar Lavage
Study: NCT05104684

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: chest physical therapy
Description: The program will consist of postural drainage, diaphragmatic breathing exercises, coughing, huffing, percussion, shaking, and exercise training using an incentive spirometer in addition to routine medical treatment

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: routine medical treatment
Description: medical treatment

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: routine medical treatment
Description: medical treatment
Study: NCT05320133

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JWC containing quadruple therapy
Description: Subjects will receive the rabeprazole 10mg, moxycillin 1.0g, clarithromycin 500mg and Jinghua Weikang Capsule 240mg twice daily for 14 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bismuth-containing quadruple therapy
Description: Subjects will receive the rabeprazole 10mg, moxycillin 1.0g, clarithromycin 500mg and bismuth potassium citrate 220mg twice daily for 14 days.
Study: NCT05600582

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaLytic
Description: CodaLytic is a virotherapeutic product based on the wild-type influenza strain A/California/07/2009

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaLytic
Description: CodaLytic is a virotherapeutic product based on the wild-type influenza strain A/California/07/2009

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaLytic
Description: CodaLytic is a virotherapeutic product based on the wild-type influenza strain A/California/07/2009

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaLytic
Description: CodaLytic is a virotherapeutic product based on the wild-type influenza strain A/California/07/2009
Study: NCT06508229

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: adebrelimab, IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albumin paclitaxel
Description: albumin paclitaxel, iv

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nedaplatin
Description: Nedaplatin，IV
Study: NCT05799794

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervisor-led Implementation Coaching
Description: Implementation coaching, support, or facilitation includes the support provided to supervisors and their organizations for successfully delivering an evidence-based practice (EBP). Implementation support can include consultation, supervision, and coaching.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supervisor-led Implementation Coaching
Description: Implementation coaching, support, or facilitation includes the support provided to supervisors and their organizations for successfully delivering an evidence-based practice (EBP). Implementation support can include consultation, supervision, and coaching.
Study: NCT06485466

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: TACE plus camrelizumab and apatinib
Description: TACE plus camrelizumab and apatinib group:~Patients who were randomized to this group, TACE is performed via an injection into the hepatic artery of agents by puncturing the common femoral artery.Adriamycin(30 to 60 mg) and oxaliplatin (50-150mg) are considered as basic chemotherapy drugs in the process of transcatheter endovascular perfusion. The dose of lipiodol (5-20ml) and other embolic agent( blank microspheres/ PVA/gelatin sponge particles) were determined by diameter and blood supply type of HCC. Within 1 week after first TACE treatment, camrelizumab 200mg intravenously every 3 weeks and apatinib 250 mg orally once daily.

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Camrelizumab and apatinib
Description: Camrelizumab and apatinib group:~Patients who were randomized to this group, camrelizumab 200mg intravenously every 3 weeks and apatinib 250 mg orally once daily.
Study: NCT04891107

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Walking Program with a Music-based, Rhythm-modulating Wearable Sensor System
Description: Participants will walk using the music-based, rhythm-modulating wearable sensor system (foot sensors, mobile device with mobile app and headphones) for thirty (30) minutes at a time, 5 times a week for 4 weeks.
Study: NCT05949489

Intervention type: DIAGNOSTIC_TEST
Intervention: WOMAC pain subscale
Description: The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale is a self-reported questionnaire that is used to measure pain in people with osteoarthritis (OA). The subscale consists of five items that ask about the intensity, frequency, and duration of pain in the hip and knee joints.~The WOMAC Pain Subscale has been shown to be a reliable and valid measure of pain in people with OA. It has been used in a number of clinical trials and is considered to be a standard measure of pain in OA.~The WOMAC Pain Subscale is scored on a scale of 0 to 4, with 0 indicating no pain and 4 indicating severe pain. The total score for the subscale is the sum of the scores for the five items. A higher score indicates more pain.
Study: NCT06195189

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunvozertinib
Description: Sunvozertinib 200mg Quaquedie (QD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Pemetrexed +platinum
Study: NCT05246813

Intervention type: OTHER
Intervention: Blood and bone marrow cell collection
Description: Collection of blood and bone marrow

Intervention type: OTHER
Intervention: Blood and bone marrow cell collection
Description: Collection of blood and bone marrow
Study: NCT05243303

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active taVNS
Description: A bipolar clip electrode is placed at the cymba conchae of the ear. Through this bipolar clip electrode, afferent nerve fibers within the auricular branch of the vagus nerve will be stimulated. Subjects self-administer the stimulation on a daily basis for 3 months.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham taVNS
Description: A bipolar clip electrode is placed at the cymba conchae of the ear. However, active stimulation of the afferent nerve fibers within the auricular branch of the vagus nerve will not occur, because the electrode wire is electrically interrupted. Subjects self-administer the sham taVNS on a daily basis for 3 months.
Study: NCT04839445

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia + TAP block
Description: Post induction TAP block for intra and postoperative analgesia.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia + ESP block
Description: Pre induction ESP block for intra and postoperative analgesia.
Study: NCT05392036

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: baseline physical therapy treatment along with shockwave therapy
Description: Group A, this group will receive conventional therapies along with shockwave therapy. Basic treatment includes icing (15-20 min) to control inflammation, rest, cessation of pain causing activity, anti-inflammatory (NSAIDs) and basic stretching and strengthening exercises. Shockwave therapy is a non-invasive therapeutic modality with convenience, effectiveness and safety. It is used to treat various musculoskeletal disorders without surgery. A session of 30-45 min will include icing 15 min and 5-10 min of shock wave therapy session will be commenced with strengthening and stretching exercises.

Intervention type: OTHER
Group type: OTHER
Intervention: baseline physical therapy treatment along with therapeutic ultrasound
Description: This group will receive therapeutic ultrasound along with conventional treatment. Conventional therapy includes icing, rest, anti-inflammatory drugs, and basic strengthening and stretching exercises. A session of 30-45 min will include icing for 10-15 min therapeutic ultrasound 15min with a frequency 1-3MHz and the session will be ended with strengthening and stretching exercises.~Only eligible patients who have fulfilled the inclusion criteria will be included. A daily session of 30-45min for 2 consecutive weeks will be given. A baseline assessment will be done and the patient will be allocated randomly to both groups for two weeks. Re-assessment will be done after 2 weeks. For long term, effects re-assessment will be done after 6 weeks
Study: NCT05492357

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Liquid platelet-rich fibrin
Description: Liquid platelet-rich fibrin is prepared from the patient's blood and injected into the extraction socket every two weeks (up to 3 months = Just 4 times of application)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced Platelet-rich fibrin plus
Description: A-PRF+ is placed into the extraction socket immediately after tooth extraction

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced Platelet-rich fibrin plus
Description: A-PRF+ is placed into the extraction socket immediately after tooth extraction
Study: NCT04829253

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy -3-months
Description: Modification of affect regulation, behavioral regulation, interpersonal functioning and identity functioning through the use of skills training, phone check-ins, crisis management and individual initial assessment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dialectical Behavior Therapy -6-months
Description: Modification of affect regulation, behavioral regulation, interpersonal functioning and identity functioning through the use of skills training, individual psychotherapy, coaching calls and treatment-team consultation.